Laser-induced lithotripsy and photodynamic therapy in urology - A short introduction to current laser applications

Medical Laser Application

Volumn 25, Issue 1, 2010, Pages 14-19

  Waidelich, Raphaela ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bladder cancer; Laser lithotripsy; Photodynamic therapy; Ureteroscopy (URS); Urinary calculi; Urology

Indexed keywords

BLADDER CANCERS; LASER LITHOTRIPSY; URETEROSCOPY; URINARY CALCULI; URINARY CALCULUS;

BIOMINERALIZATION; HOLMIUM; LASER APPLICATIONS; OPTICAL MATERIALS; PATHOLOGY; PLASMONS; UROLOGY;

PHOTODYNAMIC THERAPY;

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; ETIOPURPURIN; LU TEX; LUTETIUM TEXAPHYRIN; PALLADIUM BACTERIOPHEOPHORBIDE; PHOTOFRIN; PORPHYRIN DERIVATIVE; SNET2; TEMOPORFIN; TIN ETHYL ETIOPURPURIN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CLINICAL TRIAL; DRUG EFFICACY; EXTRACORPOREAL LITHOTRIPSY; HOLMIUM LASER; HUMAN; LASER LITHOTRIPSY; NEODYMIUM LASER; PERCUTANEOUS NEPHROLITHOTOMY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PROSTATE CANCER; PROSTATE CARCINOMA; TRANSITIONAL CELL CARCINOMA; URETER STONE; URETEROSCOPE; UROLITHIASIS; UROLOGY;

EID: 76349108521     PISSN: 16151615     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mla.2009.11.003     Document Type: Article

References (56)

1. Chan K.F., Pfefer T.J., Teichman J.M., and Welch A.J. A perspective on laser lithotripsy: the fragmentation processes. J Endourol 15 3 (2001) 257-273
2. Pierre S., and Preminger G.M. Holmium laser for stone management. World J Urol 25 3 (2007) 235-239
3. Francesca F., Scattoni V., Nava L., Pompa P., Grasso M., and Rigatti P. Failures and complications of transurethral ureteroscopy in 297 cases: conventional rigid instruments vs. small caliber semirigid ureteroscopes. Eur Urol 28 2 (1995) 112-115
4. Yaycioglu O., Guvel S., Kilinc F., Egilmez T., and Ozkardes H. Results with 7.5F versus 10F rigid ureteroscopes in treatment of ureteral calculi. Urology 64 4 (2004) 643-646 ; discussion 646-7
5. Yates J., Zabbo A., and Pareek G. A comparison of the FREDDY and holmium lasers during ureteroscopic lithotripsy. Lasers Surg Med 39 8 (2007) 637-640
6. Kijvikai K., Haleblian G.E., Preminger G.M., and de la Rosette J. Shock wave lithotripsy or ureteroscopy for the management of proximal ureteral calculi: an old discussion revisited. J Urol 178 4 Pt 1 (2007) 1157-1163
7. Johnson D.B., and Pearle M.S. Complications of ureteroscopy. Urol Clin North Am 31 1 (2004) 157-171
8. Seitz C., Tanovic E., Kikic Z., and Fajkovic H. Impact of stone size, location, composition, impaction, and hydronephrosis on the efficacy of holmium:YAG-laser ureterolithotripsy. Eur Urol 52 6 (2007) 1751-1759
9. Preminger G.M., Tiselius H.G., Assimos D.G., Alken P., Buck A.C., Gallucci M., et al. Guideline for the management of ureteral calculi. Eur Urol 2007 52 6 (2007) 1610-1631
10. Breda A., Ogunyemi O., Leppert J.T., and Schulam P.G. Flexible ureteroscopy and laser lithotripsy for multiple unilateral intrarenal stones. Eur Urol 55 5 (2009) 1190-1196
11. Breda A., Ogunyemi O., Leppert J.T., Lam J.S., and Schulam P.G. Flexible ureteroscopy and laser lithotripsy for single intrarenal stones 2 cm or greater - is this the new frontier?. J Urol 179 3 (2008) 981-984
12. Turna B., Stein R.J., Smaldone M.C., Santos B.R., Kefer J.C., Jackman S.V., et al. Safety and efficacy of flexible ureterorenoscopy and holmium:YAG lithotripsy for intrarenal stones in anticoagulated cases. J Urol 179 4 (2008) 1415-1419
13. Watterson J.D., Girvan A.R., Cook A.J., Beiko D.T., Nott L., Auge B.K., et al. Safety and efficacy of holmium: YAG laser lithotripsy in patients with bleeding diatheses. J Urol 168 2 (2002) 442-445
14. Dash A., Schuster T.G., Hollenbeck B.K., Faerber G.J., and Wolf Jr. J.S. Ureteroscopic treatment of renal calculi in morbidly obese patients: a stone-matched comparison. Urology 60 3 (2002) 393-397 ; discussion 397
15. Andreoni C., Afane J., Olweny E., and Clayman R.V. Flexible ureteroscopic lithotripsy: first-line therapy for proximal ureteral and renal calculi in the morbidly obese and superobese patient. J Endourol 15 5 (2001) 493-498
16. Chew B.H., Lange D., Arsovska O., Leung R., Paterson R.F., Teichman J.M., et al. A multicenter comparison of the safety and effectiveness of ureteroscopic laser lithotripsy in obese and normal weight patients. J Urol 181 4 Suppl. (2009) 587
17. Deliveliotis C., Picramenos D., Alexopoulou K., Christofis I., Kostakopoulos A., and Dimopoulos C. One-session bilateral ureteroscopy: is it safe in selected patients?. Int Urol Nephrol 28 4 (1996) 481-484
18. Hollenbeck B.K., Schuster T.G., Faerber G.J., and Wolf Jr. J.S. Safety and efficacy of same-session bilateral ureteroscopy. J Endourol 17 10 (2003) 881-885
19. Bilgasem S., Pace K.T., Dyer S., and Honey R.J. Removal of asymptomatic ipsilateral renal stones following rigid ureteroscopy for ureteral stones. J Endourol 17 6 (2003) 397-400
20. Lifshitz D.A., and Lingeman J.E. Ureteroscopy as a first-line intervention for ureteral calculi in pregnancy. J Endourol 16 1 (2002) 19-22
21. Watterson J.D., Girvan A.R., Beiko D.T., Nott L., Wollin T.A., Razvi H., et al. Ureteroscopy and holmium:YAG laser lithotripsy: an emerging definitive management strategy for symptomatic ureteral calculi in pregnancy. Urology 60 3 (2002) 383-387
22. Krambeck A.E., Handa S.E., and Lingeman J.E. Treatment of bladder calculi at time of holmium laser enucleation of the prostate: benefits of laser fragmentation. J Urol 181 4 Suppl. (2009) 129
23. Ramakrishnan P.A., Medhat M., Al-Bulushi Y.H., Gopakumar K.P., Sampige V.P., and Al-Busaidy S.S. Holmium laser cystolithotripsy in children: initial experience. Can J Urol 12 6 (2005) 2880-2886
24. Smaldone M.C., Cannon Jr. G.M., Wu H.Y., Bassett J., Polsky E.G., Bellinger M.F., et al. Is ureteroscopy first line treatment for pediatric stone disease?. J Urol 178 5 (2007) 2128-2131 ; discussion 2131
25. Raza A., Smith G., Moussa S., and Tolley D. Ureteroscopy in the management of pediatric urinary tract calculi. J Endourol 19 2 (2005) 151-158
26. Tan A.H., Al-Omar M., Denstedt J.D., and Razvi H. Ureteroscopy for pediatric urolithiasis: an evolving first-line therapy. Urology 65 1 (2005) 153-156
27. El-Assmy A., Hafez A.T., Eraky I., El-Nahas A.R., and Safety E.-K.HA. outcome of rigid ureteroscopy for management of ureteral calculi in children. J Endourol 20 4 (2006) 252-255
28. Canes D., and Desai M.M. New technology in the treatment of nephrolithiasis. Curr Opin Urol 18 2 (2008) 235-240
29. Mues A.C., Teichman J.M., and Knudsen B.E. Evaluation of 24 holmium:YAG laser optical fibers for flexible ureteroscopy. J Urol 182 1 (2009) 348-354
30. Qiu J., Teichman J.M., and Milner T.E. Femtosecond laser lithotripsy. J Urol 181 4 Suppl (2009) 726-727
31. Desai M.M., Haber G.P., Miranda M., Aron M., Grover R., Ganpule A., et al. Remote robotic ureteroscopic holmium laser lithotripsy for renal calculi: first clinical report. J Urol 179 4 Suppl. (2008) 542
32. Jocham D., Baumgartner R., Stepp H., and Unsöld E. Clinical experience with the integral photodynamic therapy of bladder carcinoma. J Photochem Photobiol B 6 1-2 (1990) 183-187
33. D'Hallewin M.A., and Baert L. Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder. Urology 45 5 (1995) 763-767
34. Kriegmair M., Waidelich R., Lumper W., Ehsan A., Baumgartner R., and Hofstetter A. Integral photodynamic treatment of refractory superficial bladder cancer. J Urol 154 4 (1995) 1339-1341
35. Nseyo U.O., DeHaven J., Dougherty T.J., Potter W.R., Merrill D.L., Lundahl S.L., et al. Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience. J Clin Laser Med Surg 16 1 (1998) 61-68
36. Krammer B., and Plaetzer K. ALA and its clinical impact, from bench to bedside. Photochem Photobiol Sci 7 3 (2008) 283-289
37. Waidelich R., Hofstetter A., Stepp H., Baumgartner R., Weninger E., and Kriegmair M. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors. J Urol 159 2 (1998) 401-404
38. Waidelich R., Stepp H., Baumgartner R., Weninger E., Hofstetter A., and Kriegmair M. Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer. J Urol 165 6 Pt 1 (2001) 1904-1907
39. Verigos K., Stripp D.C., Mick R., Zhu T.C., Whittington R., Smith D., et al. Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer. J Environ Pathol Toxicol Oncol 25 1-2 (2006) 373-387
40. Patel H., Mick R., Finlay J., Zhu T.C., Rickter E., Cengel K.A., et al. Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen. Clin Cancer Res 14 15 (2008) 4869-4876
41. Moore C.M., Nathan T.R., Lees W.R., Mosse C.A., Freeman A., Emberton M., et al. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer. Lasers Surg Med 38 5 (2006) 356-363
42. Selman S.H., Albrecht D., Keck R.W., Brennan P., and Kondo S. Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate. J Urol 165 5 (2001) 1795-1801
43. Pinthus J.H., Bogaards A., Weersink R., Wilson B.C., and Trachtenberg J. Photodynamic therapy for urological malignancies: past to current approaches. J Urol 175 4 (2006) 1201-1207
44. Weersink R.A., Bogaards A., Gertner M., Davidson S.R., Zhang K., Netchev G., et al. Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities. J Photochem Photobiol B 79 3 (2005) 211-222
45. Kashtan H., Haddad R., Greenberg R., Skornick Y., and Kaplan O. A non-laser light source for photodynamic therapy: in vitro effects on normal and malignant cells. J Med 33 1-4 (2002) 93-104
46. Waidelich R., Beyer W., Knüchel R., Stepp H., Baumgartner R., Schröder J., et al. Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source. Urology 61 2 (2003) 332-337
47. Kelly J.F., and Snell M.E. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol 115 2 (1976) 150-151
48. Marti A., Jichlinski P., Lange N., Ballini J.P., Guillou L., Leisinger H.J., et al. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer. J Urol 170 2 Pt 1 (2003) 428-432
49. Jichlinski P. Photodynamic applications in superficial bladder cancer: facts and hopes!. J Environ Pathol Toxicol Oncol 25 1-2 (2006) 441-451
50. Stavropoulos N.E., Kim A., Nseyo U.U., Tsimaris I., Chung T.D., Miller T.A., et al. Hypericum perforatum L. extract - novel photosensitizer against human bladder cancer cells. J Photochem Photobiol B 84 1 (2006) 64-69
51. Kamuhabwa A.R., Huygens A., Roskams T., and De Witte P.A. Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin. Int J Oncol 28 3 (2006) 775-780
52. Moore C.M., Pendse D., and Emberton M. Photodynamic therapy for prostate cancer - a review of current status and future promise. Nat Clin Pract Urol 6 1 (2009) 18-30
53. Nathan T.R., Whitelaw D.E., Chang S.C., Lees W.R., Ripley P.M., Payne H., et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. J Urol 168 4 Pt 1 (2002) 1427-1432
54. Johansson A., Axelsson J., Andersson-Engels S., and Swartling J. Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate. Med Phys 34 11 (2007) 4309-4321
55. Li J., and Zhu T.C. Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy. Phys Med Biol 53 8 (2008) 2103-2114
56. Davidson S.R., Weersink R.A., Haider M.A., Gertner M.R., Bogaards A., Giewercer D., et al. Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer. Phys Med Biol 54 8 (2009) 2293-2313